HER2-ADC trastuzumab rezetecan (SHR-A1811) in HER2-positive breast cancer with brain metastases: Update results from REIN trial.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Min Yan, Huimin Lv, Huiping Li, Limin Niu, Yajing Feng, Ran Ran, Mengwei Zhang, Jing Wang, Zhenzhen Liu, Huihui Sun, Yaowen Cui, Hanfang Jiang, Xu Liang, Lu Wang, Huiai Zeng, Shengnan Zhao, Ruyan Zhang, Yaxin Liu, Jianfei Wang
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410804881